Pre Next

PDF Download

[1] Chen Bin Zhao Hongli,.Effect of Liujunzi Decoction and Danshen Decoction on Patients with Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome [J]. Modern Traditional Chinese Medicine, 2019, (03): 42-45. [doi: 10.13424/j.cnki.mtcm.2019.03.014]

Copy

Effect of Liujunzi Decoction and Danshen Decoction on Patients with Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 2019 03 pagination: 42-45 Column: Publication date: 2019-05-30

Article number:: 1672-0571(2019)03-0042-04

Author(s):: Chen Bin 1 Zhao Hongli 2; 1. Yulin District TCM Hospital of Yulin, Community Health Service Center in Qingshan Road of Yuyang District, Yulin China, 719000; 2. First Staff Hospital of Xincheng District in Xi’ an, Xi’ an China, 710038

Keywords:: coronary heart disease; Liujunzi Decoction; interventional therapy; stent; Qi deficiency and blood stasis

ZTFLH:: R256.22

DOI:: 10.13424/j.cnki.mtcm.2019.03.014

Code:: A

Abstract:: To explore the effect of Liujunzi Decoction and Danshen Decoction on in - stent restenosis in patients with coronary heart disease( CHD) with Qi deficiency and blood stasis syndrome after percutaneous coronary intervention. Methods: 95 patients with Qi deficiency and blood stasis syndrome who were admitted to our hospital from January 2015 to January 2017 were randomly divided into control group and treatment group according to random number table. All patients were treated by percutaneous coronary intervention. The control group was treated with nitrate esters,statins, aspirin and clopidogrel. On this basis, the patients in the treatment group were treated with Liujunzi Decoction and Danshen Decoction. All patients were treated for 3 months. The scores of Qi deficiency and syndrome, restenosis rate of stent and blood stasis before and after treatment were recorded, and the clinical effects of the two groups were compared. Results: There was no significant difference in TCM syndrome score, Qi deficiency syndrome score and blood stasis syndrome score between the two groups before treatment ( all P > 0. 05) ; TCM syndrome score and blood stasis syndrome score of the two groups after treatment were significantly better than those before treatment ( all O < 0. 05) ; Qi deficiency syndrome score of the treatment group after treatment was significantly better than that before treatment, and TCM syndrome and blood stasis syndrome of the treatment group after treatment were significantly better than those of the control group in the same period ( all P < 0. 05) . The restenosis rate in the treatment group was 4. 17%, which was significantly lower than that in the control group ( 19. 15% ( 2 = 9. 374, P < 0. 05) . The total effective rate of the treatment group was 95. 83%, which was significantly higher than 87. 23% of the control group ( 2 = 11. 444, P < 0. 05) . Conclusion: Liujunzi Decoction combined with Danshen Decoction can effectively improve in - stent restenosis in patients with coronary heart disease with Qi deficiency and blood stasis syndrome after percutaneous coronary intervention. The therapeutic effect is remarkable, and it is worthy of clinical application.

References:

[1]赵宗磊,杜松,罗萍,等.益气活血法治疗不稳定型心绞痛PCI术后支架内再狭窄临床研究[J].中医学报,2017,32(11):2200-2203.
[2] Waldmann V, Laredo M, Nigam A, et al. Cyclical sinusbradycardia and atrioventricular block induced by ticagrelor[ J] . HeartRhythm Case Rep, 2018, 4( 11) : 527-529.
[3]仇卫锋,刘佳,向宗兴,等.加味丹参饮对冠心病血管内皮细胞损伤后细胞形态学的影响[J].陕西中医,2016,37(8):1042-1043.
[4] Liu Q, Fan J, Bai J, et al. IL - 34 promotes foam cellformation by enhancing CD36 expression through p38MAPK pathway[ J] . Sci Rep, 2018,8( 1) :17347.
[5]陈浩,邓悦.冠心病心绞痛代谢组学的证候客观化研究[J].世界科学技术-中医药现代化,2017,19(5):797-803.
[6] Fishman SL, Sonmez H, Basman C, et al. The role of advanced glycation end - products in the development of coronary artery disease in patients with and without diabetesmellitus: a review[ J] . Mol Med, 2018,24( 1) :59.
[7]杨威,宁微,李滕等.养心氏片治疗气虚血瘀型冠心病PCI术后心绞痛的临床观察[J].世界中医药,2018,13(3):614-615. [ 8] Sani CM, EPL P, Hrabia JB, et al. Association betweenlow - grade chronic inflammation and depressed left atrialcompliance in heart failure with preserved ejection fraction: A retrospective analysis [ J] . Folia Med Cracov,2018,58( 2) :45 -55.
[9]Sunyecz IL, McCallinhart PE, Patel KU, et al. DefiningCoronary Flow Patterns: Comprehensive Automation ofTransthoracic Doppler Coronary Blood Flow[ J] . Sci Rep,2018,8( 1) :17268.
[10]胡国恒,王瑾茜,刘侃,等.益气活血组方治疗冠心病心肌缺血的临床观察[J].中国中医急症,2016,25(10):1940-1942.
[11]唐胜,沈建锋,谢玉华,等.自拟益气活血方治疗冠心病慢性心力衰竭临床效果及对炎症因子水平的影响[J].河北中医药学报,2018,33(1):11-14.
[12] Mehta SR. Nonculprit Lesion Intervention: 1 Step Closerto the COMPLETE Answer[ J] . JACC Cardiovasc Interv,2018,11( 22) :2274 -2275.
[13]汪强,谷惠敏,朱建中,等.补阳还五汤治疗气虚血瘀型冠心病心绞痛的临床回顾性研究[J].南京中医药大学学报,2017,33(6):579-582.
[14] Hu PT, Jones WS, Glorioso TJ, et al. Predictors andOutcomes of Staged Versus One - Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program[ J] . JACC Cardiovasc Interv, 2018,11( 22) :2265 -2273.
[15]郑丽莉.芎归六君子汤对实验性大鼠冠心病的治疗作用[J].中国比较医学杂志,2018,28(1):23-27,55.
[16] Garcia S, Bhatt DL, Gallagher M, et al. Strategies toReduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial [ J] . JACCCardiovasc Interv, 2018,11( 22) :2254 -2261.

Last Update: 2019-05-15